Review Article
Treatment of Neuroendocrine Tumor Liver Metastases
Table 4
Summary of outcomes for liver transplantation for neuroendocrine metastases.
| | Author, publication year | Number of liver transplant (LT) patients | Survival data | Predictors of survival |
| |
Gedaly et al., 2011 [34] | 150
(13 receiving another organ at time of LT) | 49% 5-year survival | Improved survival with patients waiting more than 2 months for transplant (), esp. in patients >55 years old |
| |
Mathe et al., 2011 [35] | 89 | 44% 5-year survival | 0% survival if >55 years old undergoing simultaneous pancreatic resection |
| |
Le Treut et al., 2008 [36] | 85
(34 with concurrent extrahepatic resection) | Median OS: 56 months | Exenteration, duodeno-pancreatic primary, and hepatomegaly were indicators of poor prognosis (all RR of death > 2.6) |
| |
Rosenau et al., 2002 [37] | 19 | 50% 10-year survival | Ki-67 <5% and normal E-cadherin expression had 100% 7-year survival |
|
|
